Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale. - Wikidata - awgldk - TriplyDB

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

http://www.wikidata.org/entity/Q34089056

about

Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders.Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample.Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study Enhanced creative thinking under dopaminergic therapy in Parkinson disease.Impulse control and related disorders in Parkinson's disease.Behavioral effects of levodopa.Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA.Diagnosis and treatment of impulse control disorders in patients with movement disorders Impulse control disorders in Parkinson's disease: background and update on prevention and management.Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome Parkinson's Impulse-Control Scale for the Severity Rating of Impulse-Control Behaviors in Parkinson's Disease: A Semistructured Clinical Assessment Tool.Impulsive-compulsive behaviors in parkin-associated Parkinson disease.Dopaminergic modulation of performance monitoring in Parkinson's disease: An event-related potential study.Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study.Initial treatment of Parkinson's disease: an update.Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.Clinical spectrum of impulse control disorders in Parkinson's disease.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease.Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease.A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.Impulse control disorders in Parkinson's disease: Predominant role of psychological determinants.Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease.Divergent Thinking in Parkinsonism: A Case-Control Study.Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.International validation of a behavioral scale in Parkinson's disease without dementia.Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease.The addiction-related gene ANKK1 in Parkinsonian patients with impulse control disorder.Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.

P2860

Q30301190-32E5D208-CE6A-4F6B-ADC7-D00C0FA520C7 Q33800742-6A2C39EA-5AD6-406A-9054-2F1EF01001BD Q34105006-AC3F9CDB-199F-4F08-AC5B-504D638A7237 Q34135756-2790C84A-20EE-4B21-A037-4784EEADDABD Q34419587-B5406181-1340-4299-99EA-0F7ED03F60E0 Q34434412-354F4539-3D86-4F21-B049-1836E7B11941 Q34452922-403AC702-454F-491B-9C04-C8522D204E12 Q34481209-C2CE536F-B973-42F4-9EB2-DCE01EC7F7E2 Q36761848-FEEE5962-9D26-4483-93E7-FD86C0B408E9 Q36768304-88B69589-E255-432B-BDC4-A0356341FC2E Q37171160-399A07FC-0814-410E-97ED-6196E965AB4F Q37316401-FF40BB9A-068B-41A2-A5E1-86B5FBB0F745 Q37360530-B20299CD-8E6E-44F6-9E3D-2C5B26B69E3F Q37602022-1D3A60EC-6934-4966-87D5-55EFA2A1E0BC Q37633170-31475C34-3938-4BF7-9241-9A1B6E31C2A7 Q37635622-AD89B860-1351-4349-B583-F3FF9EA93AE9 Q38104296-93A59928-549C-4F07-BBA4-43C1926D78F6 Q38211499-AF355646-3944-42F5-993A-54488C4C062E Q38265050-C09146FF-6A32-4D71-A83C-F196CD71D86F Q38662579-5C9A2DBC-3CAC-4CC3-B6DC-B9F3AA775FCB Q38676636-3F658B58-4273-4951-829C-42773A2DF518 Q38926121-C5B826B6-6061-41FF-8FEC-B6F8943B082A Q39773537-F1A6FDDA-C549-4AFD-9787-31543808CB1E Q40530060-2ADDF2C7-6C4F-4EF2-9B00-29E8D2AF0181 Q44650147-88A1DF2B-C182-435A-A1A8-893217BAAB31 Q45354774-DC196BD4-8E05-4F13-A641-8EF5BFF25C83 Q45718113-3DCCBFDF-9F38-4936-84FA-AB45273C7C7E Q47290343-9DE9BDC1-3F0B-47E8-8724-D07052388776 Q47849289-253FE3E3-D4CD-49BF-8EC8-2FCB8866D869 Q48053905-A65647F3-BAA4-454F-A6CE-1EA9B18A75D0 Q48088853-53D2B720-263C-4F7C-A67C-02CE072F63A4 Q48096358-43511E8A-6EE5-4385-9B76-0B1D7BDBB068 Q48272070-A2A8FF5C-5A05-4DEC-A7CC-24F350F0E867 Q48345017-6DBB48BE-C8A6-413D-8D38-DD32ED2BF512 Q48615659-B23C940C-9201-426A-B976-54349D1FDE1C Q48631955-67A91FD0-F721-43BD-A939-26EBA1EFF758 Q50982859-A8CF2F37-1859-4AA9-8DB6-E89A9BAD5045 Q52306082-90ADAE51-5927-4EC5-92C5-A89AEC0B0D6B Q52315876-7C6C3820-2BB1-484E-B125-8F4E60ABB085 Q52316493-66D1E59E-412A-442B-B94E-EDD08FA6147F

P2860

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

http://www.wikidata.org/entity/Q34089056

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@ast

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@en

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@nl

type

label

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@ast

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@en

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@nl

prefLabel

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@ast

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@en

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@nl

P1433

Q34089056-633F6329-1C6B-4300-A981-BEEF71790F7B

P1476

Q34089056-08A7E9FB-C6DC-4D51-9911-4670C4FE1695

P2093

Q34089056-3681C09F-83EA-459A-B2B2-2C0F59C646D0

Q34089056-3C36DCA4-D696-4A08-8FB3-DA13BFFA3E98

Q34089056-572A30BB-A8B0-46A1-9717-AE958CD50992

Q34089056-62540AC9-DFF2-43FE-8401-04CD69FD201A

P2860

Q34089056-03EA972C-F5CB-45C3-9EA1-6AAEED39AAD7

Q34089056-086C9144-2B73-4909-9049-4DCC8E2790A8

Q34089056-09A68F17-0066-47A8-8DF6-5A3414314DC4

Q34089056-2677FE67-C425-41FE-84EC-E8BC5A1657A8

Q34089056-39AD4578-9C23-4EE6-88A7-E5B0AD26DE09

Q34089056-405861D9-7377-4667-8613-677AAE523EB9

Q34089056-406794A2-2023-42B6-AC65-CE691E40650A

Q34089056-87A0C798-F352-4409-B82E-F638AB626AD6

Q34089056-98F82B3F-C645-401B-BF59-FF7BB62AAA4D

Q34089056-CB91AC9A-6175-47EB-A64D-865B1EA2EBC6

P304

Q34089056-8D736B45-5774-44A1-B102-FBF10F0C2C49

P31

Q34089056-B3093787-C514-44DD-A5E6-AE82A1F75B73

P356

Q34089056-807D8588-DB7B-4789-890A-514DC92E37B3

P407

Q34089056-27374BEF-10D1-4998-B229-03DE4309F054

P433

Q34089056-EC993969-F047-4F79-A65C-8FC352FD3E97

P478

Q34089056-A74C866E-A208-42C8-AF01-8F508A115854

P50

Q34089056-1D232B49-E882-4991-A367-75B972DBEECC

Q34089056-22D1211B-8207-4EE7-8781-23DEA16F6226

P577

Q34089056-7070C6D5-757D-4D1A-B1AE-D4095EF75FEA

P698

Q34089056-9B5BE917-7B37-4635-A373-4D47EFDB3A20

P921

Q34089056-0993947B-A015-40A6-B6AD-1513404A2BAC

Q34089056-FC9DF6E1-0397-4531-BCF9-367D4D319080

P932

Q34089056-2694BABC-61F2-4AE0-A9EC-9DE0C3245FBD

P356

P1433

Movement Disorders

P1476

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

@en

P2093

Eugenia Mamikonyan

http://www.w3.org/2001/XMLSchema#string

Judith A Shea

http://www.w3.org/2001/XMLSchema#string

Kimberly Papay

http://www.w3.org/2001/XMLSchema#string

Sharon X Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.

Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability

Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Medication-related impulse control and repetitive behaviors in Parkinson disease.

P304

242-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.24023

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Weintraub

Andrew Siderowf

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22134954

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3537263

http://www.w3.org/2001/XMLSchema#string